Navigation Links
DNA Genotek's Oragene(R) DNA Product Selected by The Anthony Nolan Trust for Pilot Project
Date:5/5/2010

OTTAWA, May 5 /PRNewswire/ - DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, today announced that The Anthony Nolan Trust, the UK's largest bone marrow donor registry, has selected Oragene DNA for a pilot project aimed at increasing donor recruitment. Bone marrow donor registries, also known as HLA registries, use HLA DNA testing to match leukemia patients with prospective donors. The pilot project will determine if donor recruitment can be increased significantly with the use of non-invasive, saliva-based DNA collection compared to blood collection.

The Anthony Nolan Trust has traditionally required all registry participants to have a blood sample collected either at their doctor's office or by phlebotomists at recruitment clinics. Under this pilot project, the potential donor provides a saliva sample without any assistance (for example, at home) and mails the sample back through the regular postal system, thereby facilitating and dramatically reducing the cost of the entire process. DNA samples collected with Oragene DNA are easier, safer, and faster to collect than other methods and remain stable at ambient temperature for transport and storage prior to being analyzed at the lab.

There are currently over 400,000 people included in The Anthony Nolan Trust's registry, but many more participants are needed. 70% of patients needing a transplant cannot find a compatible match from within their families and rely on registries to find an unrelated donor for life-saving procedures. Through using Oragene DNA, The Anthony Nolan Trust expects an increase in donor recruitment and therefore the likelihood of matches between those patients needing bone marrow transplants and potential donors held in their database.

Ailsa Ogilvie, director of operations at The Anthony Nolan Trust stated: "We have historically recruited new people to our register using blood samples, but our early laboratory results confirm that Oragene DNA provides the high quality DNA that we need. We are optimistic that this pilot project will simplify the recruitment process and ultimately increase the number of people willing to join our register. Following the successful completion of this pilot phase, we hope to switch completely to using saliva samples to recruit new donors to our register via Oragene DNA from late 2010."

"By streamlining the sample collection and transportation procedures, Oragene DNA enables The Anthony Nolan Trust to focus on its primary goal of increasing donor recruitment", said Ian Curry, president and CEO, DNA Genotek, Inc. "Oragene DNA provides a reliable, cost-effective, and scalable method that is ideal for bone marrow donor registries worldwide. Our product is easy to use, safe to transport through the mail and remains stable at ambient temperature for long periods of time. What we learn from this pilot project will help chart the future for The Anthony Nolan Trust and we are certainly proud to be part of this effort."

For more information on Oragene DNA, please visit www.dnagenotek.com or email us at info@dnagenotek.com. For more information on The Anthony Nolan Trust, visit http://www.anthonynolan.org.uk/

Note to Editors: The pilot project referenced in this press release is currently available in limited areas in the United Kingdom. It is not expected to be available nationally until the summer of 2010.

About DNA Genotek:

DNA Genotek focuses on providing high-quality biological sample collection products. The company's Oragene family of products present the best way to collect and preserve large amounts of DNA from saliva. The company also offers a family of products for collecting DNA from animals and livestock. The reliability and ease-of-use of the company's products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 85 countries. For more information about DNA Genotek, visit www.dnagenotek.com

About the Anthony Nolan Trust

The Anthony Nolan Trust takes back lives from leukaemia by managing and recruiting new donors to the UK's most successful bone marrow register. The Anthony Nolan Trust also undertakes vital research leading to improvements in the effectiveness and safety of bone marrow transplants.

(R) Oragene is a registered trademark of DNA Genotek, Inc.(TM)


'/>"/>
SOURCE DNA Genotek Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
3. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
4. IsoTis Receives FDA Clearance for Accell Family of Products
5. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
6. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
9. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
10. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
11. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Rhythm, ... rare genetic deficiencies that result in life-threatening ... a $41 million mezzanine round of financing ... OrbiMed, MPM Capital, New Enterprise Associates, Pfizer ... undisclosed public healthcare investment fund. Rhythm will ...
(Date:2/16/2017)... (PRWEB) , ... February 16, ... ... Albany Molecular Research Inc. has further extended its industry leading Biochemistry Services ... service offers state-of-the-art cGMP techniques and methods for the biochemical and ...
(Date:2/15/2017)... CA (PRWEB) , ... February 15, 2017 , ... ... that Park SmartScan, a powerful AFM operating software that drastically boosts productivity with single ... completely automatizes all of the functions of setting up and taking the image once ...
(Date:2/15/2017)... , Feb. 15, 2017  NASA provider SpaceX is ... to the  International Space Station  no earlier than 10:01 ... launch will begin at 8:30 a.m. on NASA Television ... Dragon spacecraft will lift off on the company,s ... Kennedy Space Center in ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
(Date:2/8/2017)... LONDON , Feb. 7, 2017 Report ... $12.5 billion by 2021 from $8.3 billion in 2016 ... from 2016 to 2021. Report Includes - An ... of global market trends, with data from 2015 and ... through 2021. - Segmentation of the market on the ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
Breaking Biology News(10 mins):